Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on October 9th, 2026 | 10:59 CEST
BioTech Rally 2027: Patents, Blockbusters and Biosimilars! The spotlight is on Bayer, Formycon, Evotec and Novo Nordisk
The storm in the pharmaceutical sector continues to gain momentum! Expiring patents and struggling healthcare systems are shaking up old, high-margin blockbuster drugs, as societal changes and government budget constraints shake the foundations of costly pharmaceutical development. As patents expire, many generic manufacturers find themselves in a race against time. Market shares are being reshuffled, heralding a new era of growth. Amid this dynamic rally, four well-known industry players are positioning themselves on different fronts to capitalize on the market shifts. After several difficult years, the Leverkusen-based pharmaceutical giant Bayer is fighting its way back with a completely revamped pipeline. Also in the fast lane is the German biosimilar hopeful from Munich, with its first products already on the market. At Hamburg-based drug discovery company Evotec, restructuring is still underway; the key driver is its state-of-the-art, AI-powered multivalent platform. Meanwhile, the Danish giant Novo Nordisk continues to ride the global obesity and diabetes wave, driving forward the next generation of its blockbuster drugs. Analysts do not have it easy, but there are plenty of opportunities for investors.
Read
Commented by André Will-Laudien on October 8th, 2026 | 07:10 CEST
Precious Metals Sell-Off – Position for Quality Now! Barrick, Agnico Eagle, Fresnillo and Lahontan Gold
Persistently high interest rates and stubborn inflation are severely limiting the US Federal Reserve's room for manoeuvre, putting noticeable pressure on financial markets and driving volatility sharply higher. With rapid rate cuts unlikely for the time being, this environment is also weighing on traditional safe-haven assets such as gold and silver. Because precious metals do not generate interest income, significant capital is flowing into interest-bearing investments, which has recently sent metal prices into a tailspin. Yesterday, silver fell below USD 60, and even gold struggled to close above USD 4,000. Yet for strategic investors, these falling prices offer an excellent opportunity to identify an attractive entry point. The current correction is clearing speculative excesses from the market and pushing prices back toward levels that look fundamentally attractive. The limited supply of physical commodities provides a solid foundation that protects against a lasting loss of value. Those who keep their nerve now and view the temporary price decline as a discount are laying the groundwork for above-average returns when the next precious-metals upswing arrives.
Read
Commented by André Will-Laudien on October 7th, 2026 | 09:10 CEST
Bridging the Skies: The European-Canadian Drone Offensive with Volatus Aerospace, Boeing, RTX and DroneShield
"If Russia is not stopped, its war machine will sooner or later turn against us," German Chancellor Friedrich Merz has warned. The current security situation is very serious, and it would certainly be preferable to avoid being drawn into such a conflict. As modern warfare is no longer fought exclusively on the ground, the global aerospace and defence industry is undergoing one of the biggest transformations in its history. Relations between Germany and Canada are also developing in a remarkably positive direction, a testament to the inner strength of the NATO alliance. The new strategic alliance aims to break through existing technological barriers and set new standards for the defence sector. At the heart of this initiative is the integration of cutting-edge sensor technology, artificial intelligence, and state-of-the-art platforms. Innovative systems for airspace surveillance and threat detection are becoming increasingly important for securing critical infrastructure. For investors, this development creates opportunities to gain exposure to a highly dynamic, rapidly evolving growth market.
Read
Commented by André Will-Laudien on October 7th, 2026 | 09:00 CEST
Droughts, Floods, Wars! Crisis-Resilient Returns with Global Food Stocks Like Unilever, MustGrow, Bayer and Kraft Heinz
Created and Published on Behalf of MustGrow Biologics Corp.
In times of heightened geopolitical and climate-related crises, the food and agriculture sector is emerging as an increasingly critical industry. Droughts, storms, and devastating floods are presenting the global food industry with ever-greater challenges. Companies in this sector are committed to ensuring basic food security and are also driving the adoption of more sustainable farming practices. For investors, Bayer, Unilever, MustGrow, and Kraft Heinz are being put to the test, with their fundamental strength facing increasingly difficult conditions. British consumer-goods giant Unilever, for example, is placing greater emphasis on regenerative agriculture while leveraging its portfolio of global brands. US food giant Kraft Heinz, meanwhile, is seeking to withstand inflation and volatile supply chains with its portfolio of established consumer brands. At the same time, biotech company MustGrow is positioning itself with sustainable agricultural solutions designed to address increasingly extreme weather conditions, while collaborating with crop-science specialist Bayer. Current challenges are pushing food producers' business models to their limits. A closer look at the key metrics reveals who is truly prepared for the future of food.
Read
Commented by André Will-Laudien on October 6th, 2026 | 07:40 CEST
Commodities in Overdrive: BHP and Rio Tinto Cash In While Almonty Targets Critical Metals in Greenland
What investors are witnessing in the markets now amounts to an almost tectonic shift. Energy and commodity prices are surging, while interest rates have climbed to levels not seen in seven years. The East is embracing protectionism, while the US-led West is taking an increasingly assertive stance. In this capitalist imperialism of deep pockets, the US president's territorial claims over Greenland, administered by Denmark, have added another layer of geopolitical tension. These trends extend beyond the traditional mining business and are causing significant turmoil in futures markets. The geopolitical fault line runs right through the Arctic, where Greenland, thanks to gigantic deposits such as the Tanbreez project, is in the crosshairs of the Pentagon and Western security agencies. China continues to control large parts of the global supply chain, but the strategic agreement between Washington and Copenhagen is erecting a powerful barrier. At the same time, tungsten prices on the world market are soaring, outpacing almost all other critical minerals. This indispensable industrial metal, essential for the defense industry and the AI chip sector, is subject to drastic export restrictions. These supply bottlenecks are driving Western buyers to the brink of despair. A wild mix of megalomania, panic, and sabre-rattling. Where do the opportunities lie for investors with strong nerves?
Read
Commented by André Will-Laudien on October 6th, 2026 | 07:00 CEST
Defence Boom Meets Critical Metals: Rheinmetall, Renk, Globex Mining and Hensoldt in Focus
The geopolitical turning point is bringing two sectors to the forefront: defence and critical metals. One cannot exist without the other! Consequently, this fateful alliance has triggered an unprecedented supercycle in the financial markets that extends far beyond the traditional high-tech and defence conglomerates. European defence heavyweights such as Rheinmetall, Renk, and sensor specialist Hensoldt are enjoying historic order backlogs and benefiting from government rearmament programs worth billions. This is now bringing the fundamental basis of this boom sharply into focus for investors. After all, producing defence systems of all kinds depends entirely on a secure supply of strategic and critical metals. However, massive demand for military hardware is clashing with global supply chains under extreme strain from raw material shortages and the accelerating subsidy race in the West. This is where exploration and licensing companies like Globex Mining come into their own—they possess a diversified portfolio of strategic properties in politically stable regions and secure the foundations of industrial independence. Since no modern air defence system or military microchip network can exist without copper, silver, nickel, or rare earth elements, the mining and defence technology sectors are inextricably linked on the stock market. For forward-thinking investors, this symbiosis offers rare leverage.
Read
Commented by André Will-Laudien on October 2nd, 2026 | 09:55 CEST
Heading South or Heading Higher? TUI and Lufthansa in a Fuel Crisis, RE Royalties and HelloFresh Under Scrutiny
Extremely high volatility — and almost every day. Iran threatens escalation, pushing oil prices higher, while Donald Trump publicly dreams of a quick peace deal, which could, in turn, push oil prices lower. Yesterday, however, Brent crude was trading at nearly USD 107 per barrel. Billions of dollars are being made in this back-and-forth by trading desks that operate largely outside the public eye, while questionable market activity is, of course, scrutinized mainly when it involves the average retail investor. The stock market has become a mirror reflecting just how much the world has changed. Autocratic rulers dictate the direction of attention and increasingly shape how societies interact. In the past, wars were waged over religious differences and territorial claims; today, economic interests clearly dominate, with everything else often serving as a pretext. After all, only countries close to the oil reserves have a direct interest in keeping oil prices high. Interestingly, over the past four years, the United States has risen to become the world's largest oil producer, ahead of Russia, Saudi Arabia, and Canada. Several stocks have significant exposure to these developments, particularly in the aviation and travel sectors. As always, the issue comes down to steadily rising costs. For speculative investors, some of the key players are worth a closer look.
Read
Commented by André Will-Laudien on October 1st, 2026 | 08:30 CEST
No Chips, No AI – But Without Power, Nothing Runs! Big Opportunities Await in AMD, Nvidia, HPQ Silicon and Infineon
Is the AI boom starting to overheat? The fact is, the entire tech sector is heading straight for a critical bottleneck. While the developers of the world's fastest graphics processors and accelerator hardware are driving computing power to astronomical heights, the industry's foundation is beginning to falter. At the end of the day, every neural network and every sophisticated language model is only as good as the infrastructure that keeps it alive. The next phase of technological evolution will therefore no longer be decided solely in the design studios of Silicon Valley, but at the level of efficient power supply and revolutionary materials. This is where specialized semiconductor giants and innovative pioneers in cutting-edge anode materials come into play. They provide the key technologies needed to manage the exploding energy demands of modern data centres and mobile systems. The market winner will be determined by who produces the most efficient power semiconductors and next-generation battery cells. For investors, this means betting on the right suppliers for the energy transition now will secure the most profitable positions for the tech future. We do the math!
Read
Commented by André Will-Laudien on September 29th, 2026 | 07:40 CEST
AI and Crypto Stock Movers with Rare Value: Strategy, Metaplanet, Circle Internet and Strategic Resources in Focus
Power shortages, critical metals and the next technological hurdles - we are currently heading toward a fragile environment marked by high inflation, geopolitical pressure, and rising interest rates. Central banks can hardly stray from their primary mandate of monetary stability, while alternative currencies and payment systems are casting doubt on the fiat world. The sectors mentioned are closely intertwined, as complex AI systems require vast amounts of tamper-proof, transparent data for training and reliable operation. Blockchain technology provides the ideal infrastructure by storing data in a decentralized way, cryptographically securing the origin of information, and effectively preventing manipulation. In addition, the decentralized network enables the sharing of enormous computing capacity, breaking the monopoly of large data centres and democratizing AI development. A solid infrastructure is essential for all the necessary components to work together seamlessly. At the starting point of the production chain, this primarily includes critical metals. Investors must therefore think multidimensionally to give their portfolios both growth potential and security.
Read
Commented by André Will-Laudien on September 29th, 2026 | 07:10 CEST
Takeovers and Blockbusters on the Horizon! Novo Nordisk, BioNxt and Bayer Keep Taking Center Stage
The storm continues! The biotech sector is facing a massive wave of acquisitions and the approval of new blockbuster drugs. Currently in the spotlight are, above all, the weight-loss sector, innovative drug-delivery platforms, and groundbreaking gene therapies. Major pharmaceutical companies are sitting on bulging cash reserves and are desperately seeking innovative pipelines to offset impending patent expirations. In addition, approval decisions for novel obesity treatments and cancer therapies are driving up valuations across the entire industry. Smaller research firms are making a name for themselves with revolutionary active-ingredient delivery technologies, making them coveted acquisition targets for industry giants. Artificial intelligence in clinical development is also driving major efficiency gains and attracting massive amounts of venture capital. Current market momentum shows industry consolidation is in full swing, and strategic partnerships are setting the pace. Those who stay ahead of the curve in this environment will secure strong revenues for decades to come. For investors and market observers, this realignment offers an exciting starting point with enormous growth opportunities. We dive a little deeper!
Read